Induction of thymidine phosphorylase expression by AZT contributes to enhancement of 5′-DFUR cytotoxicity
- 8 December 2006
- journal article
- Published by Elsevier BV in Cancer Letters
- Vol. 244 (2), 239-246
- https://doi.org/10.1016/j.canlet.2005.12.020
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- AZT Enhances Osteoclastogenesis and Bone LossAIDS Research and Human Retroviruses, 2004
- Expression of the Angiogenic Factor Thymidine Phosphorylase in THP-1 Monocytes: Induction by Autocrine Tumor Necrosis Factor-α and Inhibition by AspirinMolecular Pharmacology, 2003
- Experimental Studies on Potentiation of the Antitumor Activity of 5‐Fluorouracil with 3′‐Azido‐3‐deoxythymidine for the Gastric Cancer Cell Line MKN28 in vivoJapanese Journal of Cancer Research, 1997
- The activity and expression of thymidine phosphorylase in human solid tumoursEuropean Journal Of Cancer, 1996
- Expression of platelet‐derived endothelial cell growth factor/thymidine phosphorylase in human breast cancerInternational Journal of Cancer, 1995
- Association of ovarian Malignancy With Expression of Paltelet-Derived Endothelial Cell Growth FactorJNCI Journal of the National Cancer Institute, 1994
- Interactions of interferon-α2a with 5′-deoxy-5-fluorouridine in colorectal cancer cells in vitroEuropean Journal Of Cancer, 1992
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Activation of 5'-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors.CHEMICAL & PHARMACEUTICAL BULLETIN, 1983
- Thymidine Catabolism by Normal and Leukemic Human Leukocytes*JCI Insight, 1964